Thai FDA Issues Urgent Warning Over South Korean Supplement Linked to Mass Illness
Thai health authorities have issued an urgent warning regarding a South Korean dietary supplement after over 100 health volunteers in Nan province fell ill.
The Thai Food and Drug Administration (FDA) has issued an urgent public health warning following a mass illness incident in Nan province. According to reports from Khaosod Online, 104 out of 129 health volunteers (OrSorMor) who consumed a specific dietary supplement imported from South Korea experienced acute adverse reactions during a training session.
The FDA has identified the problematic batch as Lot No. 18015, manufactured on March 20, 2026, with an expiration date of March 19, 2028. Authorities noted that the product was marketed with false and exaggerated claims, including promises to detoxify red blood cells, increase blood oxygen levels, and treat various lipid-related vascular issues.
For residents and travelers, this incident highlights the importance of verifying health products through official channels. The FDA is currently investigating the distribution of this supplement and the validity of its marketing claims. Consumers are advised to check the batch numbers of any imported supplements they may possess and to avoid products making unsubstantiated medical claims. It remains to be confirmed whether the adverse reactions were caused by a specific contaminant in this batch or an inherent issue with the product's formulation. Further updates are expected as the investigation continues.
